IE910976A1 - Compositions comprising cytotoxic agent and permeation¹enhancers - Google Patents

Compositions comprising cytotoxic agent and permeation¹enhancers

Info

Publication number
IE910976A1
IE910976A1 IE097691A IE97691A IE910976A1 IE 910976 A1 IE910976 A1 IE 910976A1 IE 097691 A IE097691 A IE 097691A IE 97691 A IE97691 A IE 97691A IE 910976 A1 IE910976 A1 IE 910976A1
Authority
IE
Ireland
Prior art keywords
weight
permeation
present
fluorouracil
composition
Prior art date
Application number
IE097691A
Other languages
English (en)
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of IE910976A1 publication Critical patent/IE910976A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IE097691A 1990-03-30 1991-03-25 Compositions comprising cytotoxic agent and permeation¹enhancers IE910976A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50248890A 1990-03-30 1990-03-30

Publications (1)

Publication Number Publication Date
IE910976A1 true IE910976A1 (en) 1991-10-09

Family

ID=23998069

Family Applications (1)

Application Number Title Priority Date Filing Date
IE097691A IE910976A1 (en) 1990-03-30 1991-03-25 Compositions comprising cytotoxic agent and permeation¹enhancers

Country Status (9)

Country Link
EP (1) EP0522006A1 (ja)
JP (1) JPH05505807A (ja)
AU (1) AU633207B2 (ja)
CA (1) CA2038969A1 (ja)
FI (1) FI924344A0 (ja)
IE (1) IE910976A1 (ja)
PT (1) PT97139A (ja)
WO (1) WO1991015210A1 (ja)
ZA (1) ZA912228B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753018B2 (en) * 1996-06-19 2002-10-03 Novartis Ag Cyclosporin-containing soft capsule preparations
PT869810E (pt) * 1996-06-19 2005-01-31 Novartis Ag Preparacoes de capsulas moles contendo ciclosporina
AU722285B2 (en) * 1996-06-19 2000-07-27 Novartis Ag Cyclosporin-containing soft capsule preparations
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
WO2005079855A1 (es) * 2004-02-23 2005-09-01 David Quintanar Guerrero Composicion promotora de penetracion a base de esteres de acidos grasos de sacarosa
AU2020328026A1 (en) * 2019-08-14 2022-03-03 Nanometics Llc (D.B.A. Phd Biosciences) Uracil dermal pharmaceutical formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE37447B1 (en) * 1972-04-05 1977-07-20 Procter & Gamble Dermatological compositions
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4849426A (en) * 1987-05-15 1989-07-18 Pearlman Dale L Method for treating actinic keratosis with cytotoxic agents

Also Published As

Publication number Publication date
FI924344A (fi) 1992-09-28
FI924344A0 (fi) 1992-09-28
AU633207B2 (en) 1993-01-21
PT97139A (pt) 1991-11-29
WO1991015210A1 (en) 1991-10-17
ZA912228B (en) 1991-12-24
AU7562091A (en) 1991-10-30
JPH05505807A (ja) 1993-08-26
CA2038969A1 (en) 1991-10-01
EP0522006A1 (en) 1993-01-13

Similar Documents

Publication Publication Date Title
CA2135925C (en) Use of glycerin in moderating transdermal drug delivery
CA2309688C (en) Penetration enhancing and irritation reducing systems
US4440777A (en) Use of eucalyptol for enhancing skin permeation of bio-affecting agents
KR0143916B1 (ko) 약물/침투 증대제 조성물과 관련된 피부자극의 감소방법
CA2217888C (en) Triacetin as a transdermal penetration enhancer
US4933184A (en) Menthol enhancement of transdermal drug delivery
US4560553A (en) Use of eucalyptol for enhancing skin permeation of bio-affecting agents
AU633207B2 (en) Compositions comprising cytotoxic agent and permeation enhancers
CA1176167A (en) Use of n,n-diethyl-m-toluamide for enhancing skin permeation of bio-affecting agents
US4762851A (en) Pyroglutamic acid esters used as dermal penetration enhancers for drugs
US4873266A (en) Menthone enhancement of transdermal drug delivery
US4888360A (en) Carvone enhancement of transdermal drug delivery
JPH01308225A (ja) 外用医薬組成物
EP1043979B1 (en) Compositions for the transdermal and dermal administration of biologically active agents
US4888362A (en) Eugenol enhancement of transdermal drug delivery
KR100390870B1 (ko) 경피투여용 항구토제 조성물 및 이를 포함하는 제제
NZ196395A (en) Topical pharmaceutical composition containing n,n-diethyl-m-toluamide